Takeda expands patient assistance program in U.S.

DEERFIELD, Ill. — Takeda Pharmaceuticals on Thursday announced that it would be expanding its Help At Hand patient assistance program for patients in the United States. 

 

The expansion will allow patients whose income is at 400% of the federal poverty level to apply for discounted or no-cost medicine under the program, which currently includes 11 of the company’s drugs. Under the expansion, a family of four whose household income is about $100,000 is now eligible for the prescription drug program. 

 

"We have expanded this program to allow more U.S. patients to gain access to Takeda medicines that can potentially improve their health,” Takeda Pharmaceuticals U.S.A president Ramona Sequeira said. “Every day, we’re placing the needs of patients at the center of what we do around the world.  This program expansion in the U.S. is one more way we’re showing patients we’re focused on their needs.”